Natural history of chronic hepatitis B virus infection
- PMID: 10921377
- DOI: 10.1046/j.1440-1746.2000.02123.x
Natural history of chronic hepatitis B virus infection
Abstract
In chronic hepatitis B virus (HBV) infection acquired during adulthood, which is the type mostly seen in the Caucasian population, there is biochemical and histologic regression after HBeAg seroconversion, and the risk of death from hepatitis B-related causes is low. In chronic HBV infection acquired during birth or early childhood, which is the type most commonly seen in the Asian population, there is a prolonged phase of immunotolerance. The immune clearance phase is characterized by multiple acute exacerbations preceeded by elevations in serum HBV DNA levels, HBeAg concentration and HBeAg/anti-HBe immune complexes. Of these patients, 2.4% may develop hepatic decompensation during the stage of HBeAg seroconversion. The development of cirrhosis occurs more frequently in patients with episodes of decompensation and with repeated severe acute exacerbations. However progression to cirrhosis can be relatively silent and can occur even in children. After HBeAg seroconversion, precore and core promotor mutations occur frequently in the Asian population. However, there is little correlation between the occurrence of these mutations and alanine aminotransferase elevation in patients who are positive for anti-HBe. Although cirrhosis develops during the process of HBeAg seroconversion, 68% of the complications of cirrhosis and of hepatocellular carcinoma occur after HBeAg seroconversion. These complications may still occur even after HBsAg seroclearance.
Similar articles
-
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol. 2000 May;15 Suppl:E25-30. doi: 10.1046/j.1440-1746.2000.02097.x. J Gastroenterol Hepatol. 2000. PMID: 10921378
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
-
Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2125-2129. doi: 10.22034/APJCP.2018.19.8.2125. Asian Pac J Cancer Prev. 2018. PMID: 30139211 Free PMC article.
-
Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.J Hepatol. 2003 Jan;38(1):98-103. doi: 10.1016/s0168-8278(02)00349-5. J Hepatol. 2003. PMID: 12480566
-
HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.World J Gastroenterol. 2014 Jun 28;20(24):7644-52. doi: 10.3748/wjg.v20.i24.7644. World J Gastroenterol. 2014. PMID: 24976702 Free PMC article. Review.
Cited by
-
Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study.Virol J. 2013 Jan 18;10:25. doi: 10.1186/1743-422X-10-25. Virol J. 2013. PMID: 23332007 Free PMC article.
-
Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection.World J Gastroenterol. 2005 Nov 21;11(43):6848-52. doi: 10.3748/wjg.v11.i43.6848. World J Gastroenterol. 2005. PMID: 16425395 Free PMC article.
-
Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.Korean J Hepatol. 2010 Sep;16(3):308-14. doi: 10.3350/kjhep.2010.16.3.308. Korean J Hepatol. 2010. PMID: 20924214 Free PMC article. Clinical Trial.
-
Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance.J Clin Microbiol. 2005 Apr;43(4):1594-9. doi: 10.1128/JCM.43.4.1594-1599.2005. J Clin Microbiol. 2005. PMID: 15814971 Free PMC article.
-
Risk factors of hepatitis B virus infection between vaccinated and unvaccinated groups among spouses in 2006 and 2014: a cross-sectional study in Beijing.Hum Vaccin Immunother. 2020;16(1):148-157. doi: 10.1080/21645515.2019.1640428. Epub 2019 Aug 1. Hum Vaccin Immunother. 2020. PMID: 31287778 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources